Autonomix Medical, Inc. (AMIX) has announced a 1-for-20 reverse stock split, which will take effect on October 24. Following this event, the company's shares will be available for trading on a post-split basis on the Nasdaq Capital Market starting October 25.
This move will reduce the total number of outstanding shares from approximately 23 million to about 1.15 million, while the authorized share count will remain unchanged at 500 million. Concurrently, shares reserved under the company's equity compensation plan will also be adjusted proportionately.
The company will continue to trade under its current ticker, 'AMIX.' Following the announcement, AMIX shares experienced an 8.08% increase in pre-market trading on the Nasdaq, with the price reaching $0.557.
